Novartis | Işletim Giderleri



Operating Expenses Değişiklik Tarih
AbbVie USD 9.61B 6.98B 2025-03
Alcon AG USD 2.11B 15M 2024-12
Almirall EUR 195.38M 68.92M 2024-06
Amgen USD 6.78B 401M 2024-12
AstraZeneca USD 9.91B 2.94B 2025-03
Autolus Therapeutics Ltd 75.89M 8.24M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Biogen USD 2.01B 13.3M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Fresenius EUR 5.16B 287M 2024-12
Fresenius Medical Care EUR 4.83B 528.89M 2024-12
Galapagos EUR 233.68M 95.46M 2025-03
Genmab DKK 4.25B 812M 2024-12
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
GRIFOLS EUR 1.6B 128.03M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
J&J USD 8.26B 10.37B 2025-03
Lonza CHF 2.52B 776M 2024-06
Merck EUR 4.22B 52M 2024-12
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Novartis USD 10.15B 579M 2024-12
Novo Nordisk 37.49B 4.64B 2024-09
Orion EUR 276.7M 65M 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Philips EUR 4.85B 806M 2024-12
Recordati EUR 394.73M 34.25M 2024-09
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 1.23B 1.31B 2024-06



Novartis Işletim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - May 2025.